Matassov, D.; DeWald, L.E.; Hamm, S.; Nowak, R.M.; Gerardi, C.S.; Latham, T.E.; Xu, R.; Luckay, A.; Chen, T.; Tremblay, M.;
et al. Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus. Vaccines 2024, 12, 858.
https://doi.org/10.3390/vaccines12080858
AMA Style
Matassov D, DeWald LE, Hamm S, Nowak RM, Gerardi CS, Latham TE, Xu R, Luckay A, Chen T, Tremblay M,
et al. Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus. Vaccines. 2024; 12(8):858.
https://doi.org/10.3390/vaccines12080858
Chicago/Turabian Style
Matassov, Demetrius, Lisa Evans DeWald, Stefan Hamm, Rebecca M. Nowak, Cheryl S. Gerardi, Theresa E. Latham, Rong Xu, Amara Luckay, Tracy Chen, Marc Tremblay,
and et al. 2024. "Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus" Vaccines 12, no. 8: 858.
https://doi.org/10.3390/vaccines12080858
APA Style
Matassov, D., DeWald, L. E., Hamm, S., Nowak, R. M., Gerardi, C. S., Latham, T. E., Xu, R., Luckay, A., Chen, T., Tremblay, M., Shearer, J., Wynn, M., Eldridge, J. H., Warfield, K., & Spurgers, K.
(2024). Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus. Vaccines, 12(8), 858.
https://doi.org/10.3390/vaccines12080858